PT952148E - Derivados de acido ciclobutil-ariloxiarilsulfonilamino-hidroxamico - Google Patents

Derivados de acido ciclobutil-ariloxiarilsulfonilamino-hidroxamico

Info

Publication number: PT952148E
Authority: PT; Portugal
Prior art keywords: cylobutil; aryloxyarilsulfonylamino; acid derivatives; hydroxymic acid; hydroxymic
Prior art date: 1998-04-10

Application number

PT99302282T

Other languages

English (en)

Inventor

Lawrence Alan Reiter

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-10

Filing date

1999-03-25

Publication date

2004-09-30

1999-03-25 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-09-30 Publication of PT952148E publication Critical patent/PT952148E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PT99302282T 1998-04-10 1999-03-25 Derivados de acido ciclobutil-ariloxiarilsulfonilamino-hidroxamico PT952148E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8139298P	1998-04-10	1998-04-10

Publications (1)

Publication Number	Publication Date
PT952148E true PT952148E (pt)	2004-09-30

Family

ID=22163854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99302282T PT952148E (pt)	1998-04-10	1999-03-25	Derivados de acido ciclobutil-ariloxiarilsulfonilamino-hidroxamico

Country Status (10)

Country	Link
US (1)	US6156798A (pt)
EP (1)	EP0952148B1 (pt)
JP (1)	JP3626366B2 (pt)
AT (1)	ATE266634T1 (pt)
BR (1)	BR9901250A (pt)
CA (1)	CA2268484C (pt)
DE (1)	DE69917124T2 (pt)
DK (1)	DK0952148T3 (pt)
ES (1)	ES2220004T3 (pt)
PT (1)	PT952148E (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ336840A (en) *	1997-02-03	2001-01-26	Pfizer Prod Inc	Arylsulfonylamino hydroxamic acid derivatives useful in the treatment of tumor necrosis factor and matrix metalloproteinase mediated diseases
US20040072889A1 (en) *	1997-04-21	2004-04-15	Pharmacia Corporation	Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
US20030225150A1 (en) *	1997-04-21	2003-12-04	Pharmacia Corporation	Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
US20030013739A1 (en) *	1998-12-23	2003-01-16	Pharmacia Corporation	Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US20020103141A1 (en) *	1998-12-23	2002-08-01	Mckearn John P.	Antiangiogenic combination therapy for the treatment of cancer
US20040053900A1 (en) *	1998-12-23	2004-03-18	Pharmacia Corporation	Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy
US20030203956A1 (en) *	1998-12-23	2003-10-30	Masterrer Jaime L.	Method of using a cyclooxygenase-2 inhibitor and one or more ornithine decarboxylase inhibitors as a combination therapy in the treatment of neoplasia
US20030119895A1 (en) *	1998-12-23	2003-06-26	Pharmacia Corporation	Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
CA2404125C (en) *	2000-03-20	2011-01-25	Merck Sharp & Dohme Limited	Sulphonamido-substituted bridged bicycloalkyl derivatives
EP1191024A1 (en) *	2000-09-22	2002-03-27	Harald Tschesche	Thiadiazines and their use as inhibitors of metalloproteinases
BR0207297A (pt)	2001-02-15	2005-04-19	King Pharmaceuticals Inc	Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
WO2003000194A2 (en)	2001-06-21	2003-01-03	Pfizer Inc.	Thienopyridine and thienopyrimidine anticancer agents
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
JPWO2003045433A1 (ja) *	2001-11-29	2005-04-07	日本オルガノン株式会社	心機能不全治療薬
PE20030701A1 (es)	2001-12-20	2003-08-21	Schering Corp	Compuestos para el tratamiento de trastornos inflamatorios
JP4313678B2 (ja) *	2001-12-27	2009-08-12	大日本住友製薬株式会社	ヒドロキサム酸誘導体およびそれを有効成分とするｍｍｐ阻害剤
MXPA05000729A (es) *	2002-07-17	2005-04-08	Warner Lambert Co	Combinacion de un inhibidor alosterico de metaloproteinasa-13 de matriz con celecoxib o valdecoxib.
MXPA05000723A (es) *	2002-07-17	2005-04-08	Warner Lambert Co	Combinacion de un inhibidor alosterico de metaloproteinasa-13 de matriz con un inhibidor selectivo de ciclooxigenasa-2 que no es celecoxib o valdecoxib.
ATE457716T1 (de)	2002-12-30	2010-03-15	Angiotech Int Ag	Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
GB0319069D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Therapeutically useful compounds
GB0326546D0 (en) *	2003-11-14	2003-12-17	Amersham Plc	Inhibitor imaging agents
ME01788B (me)	2004-08-26	2011-02-28	Pfizer	Enantiomerno čista aminoheteroaril jedinjenja kao inhibitori protein kinaza
EP1998760A2 (en) *	2006-03-30	2008-12-10	James E. Summerton	Non peptidic molecules for detecting and treating tumors
AU2007350326A1 (en) *	2007-03-30	2008-10-09	James E. Summerton	Non-peptidic molecules for detecting and treating tumors
EP2119690A1 (en) *	2008-05-14	2009-11-18	Academisch Medisch Centrum bij de Universiteit van Amsterdam	Radiolabelled MMP selective compounds
US9416132B2 (en)	2011-07-21	2016-08-16	Tolero Pharmaceuticals, Inc.	Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors
EP3924351B1 (en)	2019-02-12	2025-05-21	Sumitomo Pharma America, Inc.	Crystalline form of the hydrochloride salt of 2-((1r,4r)-4-((3-(3-(trifluoromethyl)phenyl) imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5552419A (en) *	1993-01-06	1996-09-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) *	1995-03-08	1999-01-26	Pfizer Inc	Arylsulfonylamino hydroxamic acid derivatives
EA199900139A1 (ru) *	1996-08-23	1999-08-26	Пфайзер, Инк.	Производные арилсульфониламиногидроксамовой кислоты
KR20000049198A (ko) *	1996-10-16	2000-07-25	윌리암 에이취 캘넌, 에곤 이 버그	매트릭스 메탈로프로티나아제 및 ｔａｃｅ 억제제로서의 베타-설폰아미도 하이드록스암산
HUP0002960A3 (en) *	1997-08-08	2001-12-28	Pfizer Prod Inc	Aryloxyarylsulfonylamino hydroxamic acid derivatives

1999
- 1999-03-25 PT PT99302282T patent/PT952148E/pt unknown
- 1999-03-25 DE DE69917124T patent/DE69917124T2/de not_active Expired - Fee Related
- 1999-03-25 ES ES99302282T patent/ES2220004T3/es not_active Expired - Lifetime
- 1999-03-25 EP EP99302282A patent/EP0952148B1/en not_active Expired - Lifetime
- 1999-03-25 AT AT99302282T patent/ATE266634T1/de not_active IP Right Cessation
- 1999-03-25 DK DK99302282T patent/DK0952148T3/da active
- 1999-04-08 CA CA002268484A patent/CA2268484C/en not_active Expired - Fee Related
- 1999-04-09 BR BR9901250-2A patent/BR9901250A/pt not_active IP Right Cessation
- 1999-04-09 JP JP10248699A patent/JP3626366B2/ja not_active Expired - Fee Related
- 1999-04-09 US US09/290,023 patent/US6156798A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE266634T1 (de)	2004-05-15
JP3626366B2 (ja)	2005-03-09
ES2220004T3 (es)	2004-12-01
EP0952148A1 (en)	1999-10-27
BR9901250A (pt)	2000-05-16
US6156798A (en)	2000-12-05
DK0952148T3 (da)	2004-09-20
DE69917124D1 (de)	2004-06-17
JPH11322705A (ja)	1999-11-24
DE69917124T2 (de)	2005-05-12
CA2268484C (en)	2006-02-07
EP0952148B1 (en)	2004-05-12
CA2268484A1 (en)	1999-10-10

Publication	Publication Date	Title
PT952148E (pt)	2004-09-30	Derivados de acido ciclobutil-ariloxiarilsulfonilamino-hidroxamico
MY120235A (en)	2005-09-30	Aryloxyarylsulfonylamino hydroxamic acid derivatives
DK0623607T3 (da)	1999-04-19	Benzofuranyl- og -thiophenyl-alkancarboxylsyrederivater
GB9801690D0 (en)	1998-03-25	Therapeutic agents
NO940038D0 (no)	1994-01-05	Arylsulfonamido-substituerte hydrokamsyrer
NO20002440D0 (no)	2000-05-11	Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
DE69915004D1 (de)	2004-04-01	5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
ES2151156T3 (es)	2000-12-16	Derivados de acidos n-(aroil)glicina hidroxamicos y compuestos relacionados.
PT902022E (pt)	2003-12-31	Novos derivados de benzofuranona e processo para a sua producao
EP0799827A4 (en)	1998-01-28	ACRYLAMIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DK0652208T3 (da)	1998-09-14	Phenylalkan(en)syrer
ATE280767T1 (de)	2004-11-15	Antidiabetische thiazolidindione und ihre herstellung
DZ1724A1 (fr)	2002-02-17	Nouvelles azétidinones substituées comme agents anti-inflammatoires et anti-dégénérescence.
DE69623806D1 (de)	2002-10-24	Pestizide
ES2053809T3 (es)	1994-08-01	Derivados de ciclopropano.
NO904575L (no)	1991-04-25	Benzocykloalkylaminopyridinaminer og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstillingog anvendelse som medikamenter.
ATE146472T1 (de)	1997-01-15	Umwandlungsverfahren von lorabef dihydrate in loracarbef monohydrate
BR9800281B1 (pt)	2009-05-05	processos para a preparação de cloro-benzoilcloretos, e de derivados de benzofenona cloro-substituìda.
ES2111920T3 (es)	1998-03-16	Clatratos de agua de piperazinilpiridinas.